What are the recommended adult dosing, contraindications, and side effects of polyethylene glycol (PEG) for treating constipation?

Polyethylene Glycol for Constipation: Dosing, Contraindications, and Side Effects

The American Gastroenterological Association strongly recommends polyethylene glycol (PEG) 3350 at 17 g once daily for adults with chronic idiopathic constipation, with moderate-certainty evidence supporting sustained efficacy for at least 6 months. 1

Adult Dosing

Standard Regimen

• 17 g of PEG 3350 dissolved in 4–8 ounces of liquid (cold, hot, or room temperature), taken once daily 2
• The powder must be fully dissolved before drinking; do not consume if clumps remain 2
• This dose increases complete spontaneous bowel movements by approximately 2.9 per week and spontaneous bowel movements by 2.3 per week compared to placebo 1, 3

Duration and Response

• Clinical response is durable for at least 6 months of continuous daily use 1, 3
• Most patients experience a bowel movement within 1–3 days of initiating therapy 2
• The FDA label indicates use for "occasional constipation" and recommends not exceeding 7 days without physician guidance 2, but clinical trial evidence supports chronic use up to 6 months for chronic idiopathic constipation 1

Dosing Strategies

• For mild constipation, consider a trial of fiber supplementation (particularly psyllium) before PEG or in combination with PEG 1
• Higher doses (51–85 g as a single dose) have been studied for rapid relief within 24 hours, with 68 g appearing most effective 4
• Some European formulations use PEG with electrolytes at 17.5 g twice daily (total 35 g/day) 1

Contraindications

Absolute Contraindications

• Gastrointestinal obstruction or evidence of bowel obstruction 5
• Delayed gastric emptying 5
• Severe inflammatory bowel disease 5

Relative Contraindications and Precautions

• Children 16 years of age or under require physician consultation before use 2
• Do not combine with starch-based thickeners used for dysphagia, as this may create a choking hazard 2

Side Effects

Common Adverse Effects (Mild to Moderate)

• Abdominal distension 1, 3
• Loose stools or diarrhea 1, 3
• Flatulence 1, 3
• Nausea 1, 3
• These gastrointestinal adverse events typically decrease markedly after the first week of treatment 6

Serious Adverse Events

• No serious adverse events were attributed to PEG in controlled trials 1, 3
• The confidence interval for serious adverse events includes both low and high risk, making conclusive statements difficult (RR 0.47, CI 0.16–1.33) 1

Metabolic and Nutritional Effects

• No clinically relevant changes in electrolytes, calcium, glucose, BUN, creatinine, or serum osmolality were observed in clinical trials 7, 4
• In elderly patients treated for 6 months, no significant changes in nutritional markers, vitamins, or absorption parameters occurred 8

Clinical Implementation Considerations

Treatment Algorithm

1. First-line for chronic idiopathic constipation: Start PEG 3350 17 g once daily 1, 3
2. For mild constipation: Consider fiber (psyllium) trial before or with PEG 1
3. If inadequate response: PEG has been studied at higher doses, though 17 g daily is the standard FDA-approved dose 2
4. If PEG fails or is not tolerated: Consider second-line options such as lactulose, magnesium oxide, or prescription agents 3

Key Clinical Pearls

• PEG is widely available over-the-counter and inexpensive, facilitating broad accessibility 3
• Response rates are substantial: 52% of patients achieve treatment success (defined as relief of Rome criteria for ≥50% of treatment weeks) versus 11% with placebo 7
• Using FDA responder criteria (≥3 complete spontaneous bowel movements per week plus ≥1 increase from baseline for ≥9 of 12 weeks), 42% of PEG patients respond versus 13% with placebo 6
• No requirement for periodic drug holidays exists; continuous daily use is supported 3

Common Pitfalls to Avoid

• Inadequate dissolution: Ensure powder is fully dissolved to prevent choking risk and optimize efficacy 2
• Premature discontinuation: Patients may discontinue due to early mild GI symptoms that typically resolve after the first week 6
• Underdosing in severe cases: While 17 g daily is standard, some patients with severe constipation or fecal impaction may require higher doses (up to 8 sachets of 13.8 g daily for disimpaction) 5
• Ignoring fluid intake: Standard fiber supplements should be taken with 8–10 ounces of fluid; PEG requires 4–8 ounces 1, 2

Comparative Efficacy

• PEG demonstrates superior efficacy to ispaghula husk (psyllium) in head-to-head trials, with 92% versus 73% overall efficacy rates 9
• PEG shows similar or greater efficacy than tegaserod, prucalopride, and lactulose in comparative trials, though different endpoints were used 1